Disclosure of Voting Results and Scrutinizer''s Report dated September 29, 2025.

Zenotech Laboratories held its 36th Annual General Meeting on September 26, 2025 via video conferencing. Five ordinary resolutions were put to vote through remote e-voting and e-voting during the AGM, and all passed with the requisite majority. The resolutions covered: (1) adoption of audited standalone financial statements for FY ended March 31, 2025 (99.99% in favour), (2) re-appointment of director Mr. Rakeshchandra Sinha who retires by rotation (99.89% in favour), (3) appointment of M/s. G S K A & Co., Chartered Accountants as statutory auditors (99.99% in favour), (4) approval of material related party transactions with Sun Pharmaceutical Industries Limited (95.55% in favour), and (5) appointment of Mr. Mahadev Tirunagari as secretarial auditor (99.99% in favour). Promoters, holding 4,20,14,578 shares (about 68.85% of total), voted 100% in favour on every resolution where they were eligible. On the Sun Pharma related-party transaction, the promoter group abstained (as an interested party), so only 62,051 public-non-institution votes were polled. Out of 10,935 total shareholders, only 85 members cast votes, indicating very low retail participation.